We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns French Drugmaker for Out-of-Specification Investigations
FDA Warns French Drugmaker for Out-of-Specification Investigations
Laboratoires Claires drew a warning letter from the FDA for shoddy out-of-specification investigations and other violations at its Pontoise, France facility.